Semaglutide sustains lower calorie intake for more than a year, study shows

Researchers have made a significant breakthrough in understanding the long-term effects of semaglutide, a medication commonly used for weight loss. A recent study published in the American Journal of Clinical Nutrition found that individuals taking semaglutide for weight loss continued to consume significantly fewer calories after 60 weeks of treatment. This finding provides valuable insights into how the medication supports both initial weight loss and long-term weight maintenance.

Led by investigators from Penn's Center for Weight and Eating Disorders and Penn Metabolic Medicine, the study is among the first to examine the long-term effects of semaglutide on eating behavior beyond the initial months of treatment. The results suggest that semaglutide's calorie-reducing effects persist over an extended period, which could be a crucial factor in its ability to facilitate sustainable weight loss. By shedding light on the medication's long-term effects on eating behavior, this study has the potential to inform treatment strategies for individuals struggling with weight-related issues.

The study's findings have significant implications for the treatment of obesity and weight-related disorders. As the global obesity epidemic continues to grow, understanding the mechanisms behind effective weight loss treatments is crucial for developing targeted and sustainable solutions. The results of this study contribute to our knowledge of semaglutide's efficacy and provide valuable insights for healthcare professionals working with patients seeking to achieve and maintain a healthy weight.